Dr. Benya is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1740 W Taylor St
Chicago, IL 60612Phone+1 866-600-2273Fax+1 312-996-5103
Education & Training
MedStar Health/Georgetown University HospitalFellowship, Gastroenterology, 1990 - 1991
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1986
Certifications & Licensure
IL State Medical License 1988 - 2023
FL State Medical License 2000 - 2002
MD State Medical License 1991 - 1996- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- West Suburban Living Magazine Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer Start of enrollment: 2009 Aug 20
- Colon Cancer Prevention Using Selenium Start of enrollment: 2010 Dec 01
- Polyphenon E in Treating Patients With High-Risk of Colorectal Cancer Start of enrollment: 2012 Jun 01
Publications & Presentations
PubMed
- Should We Collect a Biopsy From This Submucosal Lesion in the CecumPaul Vincent Co, Richard Benya, Mukund Venu
Gastroenterology. 2019-01-01 - 2 citationsA phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectum.Daniel L. Gillen, Frank L. Meyskens, Timothy R. Morgan, Jason A. Zell, Robert Carroll
Cancer Prevention Research. 2015-03-01 - 53 citationsDDB2 Suppresses Epithelial to Mesenchymal Transition in Colon CancerNilotpal Roy, Prashant V. Bommi, Uppoor G. Bhat, Shaumick Bhattacharjee, Indira Elangovan
Cancer Research. 2013-06-15
Grant Support
- Vitamin D And Colorectal CancerNational Cancer Institute2008–2012
- Role Of Galanin In Pathogen-Induced Colonic SecretionNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2010
- Gastrin-Releasing Peptide Receptor DesensitizationNational Cancer Institute2003–2007
- Role Of Galanin In Intestinal PathophysiologyNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2003
- Role Of Galanin In Intestinal PathophysiologyNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2001
- Gastrin Releasing Peptide Receptor DesensitizationNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2001
- Gastrin Releasing Peptide Receptor DesensitizationNational Institute Of Diabetes And Digestive And Kidney Diseases2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
